Invasive Bacterial Infections in Subjects with Genetic and Acquired Susceptibility and Impacts on Recommendations for Vaccination: A Narrative Review
- PMID: 33668334
- PMCID: PMC7996259
- DOI: 10.3390/microorganisms9030467
Invasive Bacterial Infections in Subjects with Genetic and Acquired Susceptibility and Impacts on Recommendations for Vaccination: A Narrative Review
Abstract
The WHO recently endorsed an ambitious plan, "Defeating Meningitis by 2030", that aims to control/eradicate invasive bacterial infection epidemics by 2030. Vaccination is one of the pillars of this road map, with the goal to reduce the number of cases and deaths due to Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae and Streptococcus agalactiae. The risk of developing invasive bacterial infections (IBI) due to these bacterial species includes genetic and acquired factors that favor repeated and/or severe invasive infections. We searched the PubMed database to identify host risk factors that increase the susceptibility to these bacterial species. Here, we describe a number of inherited and acquired risk factors associated with increased susceptibility to invasive bacterial infections. The burden of these factors is expected to increase due to the anticipated decrease in cases in the general population upon the implementation of vaccination strategies. Therefore, detection and exploration of these patients are important as vaccination may differ among subjects with these risk factors and specific strategies for vaccination are required. The aim of this narrative review is to provide information about these factors as well as their impact on vaccination against the four bacterial species. Awareness of risk factors for IBI may facilitate early recognition and treatment of the disease. Preventive measures including vaccination, when available, in individuals with increased risk for IBI may prevent and reduce the number of cases.
Keywords: Haemophilus influenzae; Neisseria meningitidis; Streptococcus agalactiae; Streptococcus pneumoniae; complement; genetic factors; group B streptococci; invasive bacterial infections; susceptibility.
Conflict of interest statement
M-K.T reports grants from GSK, grants from Pfizer, grants from Sanofi, outside the submitted work, M.-K.T. and A.-E.D. have a patent 630133 issued.
References
-
- World Health Organization (WHO) Defeating meningitis by 2030; Proceedings of the First Meeting of the Technical Taskforce; World Health Organization, Geneva, Switzerland. 18–19 July 2018; WHO: 2019.
-
- Pinto M., Gonzalez-Diaz A., Machado M.P., Duarte S., Vieira L., Carrico J.A., Marti S., Bajanca-Lavado M.P., Gomes J.P. Insights into the population structure and pan-genome of Haemophilus influenzae. Infect. Genet. Evol. J. Mol. Epidemiol. Evol. Genet. Infect. Dis. 2019;67:126–135. doi: 10.1016/j.meegid.2018.10.025. - DOI - PubMed
-
- Dore N., Bennett D., Kaliszer M., Cafferkey M., Smyth C.J. Molecular epidemiology of group B streptococci in Ireland: Associations between serotype, invasive status and presence of genes encoding putative virulence factors. Epidemiol. Infect. 2003;131:823–833. doi: 10.1017/S0950268803008847. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
